An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis.
An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2018 05; 19(3-4):242-249.